Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants

por Stasi, Kalliopi, Alshare, Qusai, Jain, Monish, Wald, Michael, Li, Yifang
Publicado 2022

Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study

por Burstedt, Marie, Whelan, James H., Green, Jane S., Holopigian, Karen, Spera, Claudio, Greco, Erin, Deslandes, Jean-Yves, Wald, Michael, Grosskreutz, Cynthia, Ni, Xiao, Normand, Guillaume, Maker, Michael, Charil, Arnaud, Rosol, Michael, He, Yunsheng, Stasi, Kalliopi
Publicado 2023